37 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TLX

Telix Pharmaceuticals
AU$22.20-3.1%141.8%AU$7.7bAU$25.62PE151.1xE38.3%n/a

A326030

SK Biopharmaceuticals
₩97,600.00-5.7%8.0%₩7.7t₩120,800.00PE226.2xE50.6%n/a

VRTX

Vertex Pharmaceuticals
US$451.23-8.8%27.7%US$115.4bUS$513.87PS10.9xE47.4%n/a

688266

Suzhou Zelgen BiopharmaceuticalsLtd
CN¥67.89-0.1%42.8%CN¥17.7bCN¥79.00PS36.8xE125.6%n/a

688046

GemPharmatech
CN¥13.720.1%-30.0%CN¥5.7bCN¥16.75PE40.2xE27.9%0.4%

FYB

Formycon
€47.050.2%-23.6%€830.8m€85.67PE13xE31.5%n/a

603707

Nanjing King-Friend Biochemical PharmaceuticalLtd
CN¥14.33-3.3%1.8%CN¥23.5bCN¥18.00PS6xE70.5%0.7%

688166

BrightGene Bio-Medical Technology
CN¥31.90-4.9%-16.7%CN¥13.6bCN¥41.11PE71.6xE34.8%0.3%

CLN

New
Celon Pharma
zł27.453.0%87.0%zł1.5bzł26.58PS7.1xE73.8%0.3%

9926

Akeso
HK$73.257.6%54.4%HK$63.1bHK$72.16PS32.6xE53.3%n/a

SLV

Selvita
zł52.50-4.7%-12.6%zł963.7mzł69.23PE20.3xE23.3%n/a

LLY

Eli Lilly
US$753.41-7.2%26.6%US$657.1bUS$992.18PE81.1xE29.5%0.7%

MLAB

New
Mesa Laboratories
US$98.59-8.5%12.2%US$541.8mUS$140.00PS2.3xE124.8%0.6%

4974

Takara Bio
JP¥1,057.00-5.2%-13.4%JP¥129.3bJP¥1,500.00PE140xE25.2%1.6%

ARGX

argenx
€553.60-2.8%23.2%€33.4b€577.45PS18.5xE55.5%n/a

NOVO B

Novo Nordisk
DKK 738.10-2.4%5.1%DKK 3.3tDKK 938.04PE34.5xE14.4%1.3%

002653

Haisco Pharmaceutical Group
CN¥36.207.6%50.8%CN¥39.6bCN¥42.38PE84.3xE35.7%0.8%

GXI

Gerresheimer
€70.15-5.4%-17.1%€2.4b€114.45PE21.2xE21.7%1.8%

2268

WuXi XDC Cayman
HK$26.401.0%-5.4%HK$31.6bHK$30.02PE49.5xE27.5%n/a

IBNSINA

IBN SINA Pharmaceutical Industry
৳278.40-6.6%-2.9%৳8.7b৳390.00PE14.7xE25.5%2.3%

VCYT

Veracyte
US$39.20-0.8%50.1%US$3.0bUS$42.78PS7.1xE45.6%n/a

A009420

New
Hanall Biopharma
₩36,200.00-10.6%-2.2%₩1.9t₩53,333.33PS14.1xE93.9%n/a

300294

New
China Resources Boya Bio-pharmaceutical GroupLtd
CN¥32.634.2%1.0%CN¥16.3bCN¥36.70PE88.4xE44.4%1.0%

RGEN

Repligen
US$138.90-7.7%-13.3%US$7.2bUS$192.25PS12.3xE50.9%n/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.